MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,025,621 | +20.4% | 23,545 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $851,765 | -2.3% | 23,575 | +0.6% | 0.00% | 0.0% |
Q1 2023 | $871,387 | -18.3% | 23,437 | -0.4% | 0.00% | -50.0% |
Q4 2022 | $1,066,053 | -63.9% | 23,528 | -44.3% | 0.00% | -50.0% |
Q3 2022 | $2,952,137 | +681.0% | 42,270 | +650.4% | 0.00% | +300.0% |
Q2 2022 | $378,000 | -74.4% | 5,633 | -68.6% | 0.00% | -66.7% |
Q1 2022 | $1,474,000 | -45.0% | 17,931 | -1.8% | 0.00% | -40.0% |
Q4 2021 | $2,680,000 | +33.1% | 18,267 | +60.6% | 0.01% | +25.0% |
Q3 2021 | $2,013,000 | +7.5% | 11,376 | -1.9% | 0.00% | 0.0% |
Q2 2021 | $1,873,000 | -90.5% | 11,593 | -89.9% | 0.00% | -90.0% |
Q1 2021 | $19,635,000 | -10.6% | 114,625 | +14.6% | 0.04% | -11.1% |
Q4 2020 | $21,959,000 | +942.2% | 99,982 | +687.9% | 0.04% | +800.0% |
Q3 2020 | $2,107,000 | +45.4% | 12,690 | 0.0% | 0.01% | +66.7% |
Q2 2020 | $1,449,000 | +29.1% | 12,690 | -13.0% | 0.00% | 0.0% |
Q1 2020 | $1,122,000 | -35.8% | 14,592 | +7.5% | 0.00% | -25.0% |
Q4 2019 | $1,749,000 | +111.2% | 13,575 | +27.8% | 0.00% | +100.0% |
Q3 2019 | $828,000 | -19.0% | 10,622 | +7.1% | 0.00% | 0.0% |
Q2 2019 | $1,022,000 | +63.3% | 9,919 | +16.1% | 0.00% | +100.0% |
Q1 2019 | $626,000 | +74.9% | 8,542 | +1.2% | 0.00% | 0.0% |
Q4 2018 | $358,000 | -2.5% | 8,441 | +8.2% | 0.00% | 0.0% |
Q3 2018 | $367,000 | +5.8% | 7,801 | +11.0% | 0.00% | 0.0% |
Q2 2018 | $347,000 | – | 7,029 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |